📰 Trial Expected News

Trial Expected News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Trial Expected. Real-time updates on events, politics, business and more.

Capricor Therapeutics Announces Manufacturing Scale-Up of CAP-1002 Production at New San Diego Facility as it Continues Plans Toward Commercialization

February 20, 2024

Cohort B of HOPE-3, Phase 3 Clinical Trial Expected to Complete Enrollment in Second Quarter 2024- SAN DIEGO, Feb. 20, 2024 (GLOBE NEWSWIRE) -- CAPR, a…

Trial Expected Complete Enrollment Second Quarter Reaking News

Source: biztoc.com

NeuroBo Pharmaceuticals Announces FDA Clearance of IND for a Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity

February 1, 2024

/PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today...

United Kingdom Michael Miller Ttirzepatide Mounjaro Semaglutide Wegovy Marshallh Woodworth Donga St Co

Source: prnewswire.com

Seagen Second Quarter 2023 Financial Results Demonstrate Exceptional Commercial Performance Driving Record Product Sales with Strong Growth and Momentum

August 2, 2023

-Record Net Product Sales of $544 Million in 2Q23, an Increase of 26% Over 2Q22, Contributing to Total Revenues of $604 Million in 2Q23- -Strong PADCEV® Growth Driven By Combination First-Line...

United States Disitamab Vedotin David Epstein Roger Dansey American Association For Cancer Research Seagen Inc

Source: marketscreener.com

Tenaya Therapeutics Receives FDA Fast Track Designation for TN-201

May 2, 2023

TN-201 Being Developed for the Potential Treatment of MYBPC3-associated HCM Dosing in Phase 1 Clinical Trial Expected to Commence in Q3 2023 SOUTH SAN FRANCISCO, Calif., May 02, 2023 -- Tenaya... | May 2, 2023

United States Whit Tingley Wendy Ryan Corporate Communications European Commission Drug Administration

Source: marketscreener.com

Coeptis Therapeutics Signs Agreement to Acquire Allogeneic Immuno-Oncology NK Platform in Phase 1 Clinical Trials from Deverra Therapeutics

April 18, 2023

Proposed transaction would provide Coeptis with two clinical stage assets leveraging NK cell therapies in relapsed or refractory acute myeloid leukemia and hospitalized respiratory infections, as... | April 18, 2023

David Schemelia Colleen Delaney Karolinska Institutet Jon Nugent Dave Mehalick Coeptis Pharmaceuticals Inc

Source: marketscreener.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

The Skanner News - Trial Expected to Begin for Ex-Trump Adviser Steve Bannon

July 18, 2022

Jury selection is scheduled to begin Monday in the trial of Steve Bannon, a one-time adviser to former President Donald Trump who faces criminal contempt of Congress charges

United States White House District Of Columbia Roscoe Howard Jr Ketanji Brown Jackson Donald Trump

Source: theskanner.com

Nikolas Cruz Trial Live Updates: Sentencing Hearing Now Underway

July 18, 2022

The Parkland school shooter is facing the death penalty after pleading guilty to 17 counts of first-degree murder. Follow Newsweek for the latest.

United States Nikolas Cruz Marjory Stoneman Douglas High School Trial Expected Last Four Parkland Shooting

Source: newsweek.com

Omega Therapeutics Announces FDA Clearance of IND Application for OTX-2002, First Omega Epigenomic Controller, for MYC Driven Hepatocellular Carcinoma

July 14, 2022

/PRNewswire/ -- Omega Therapeutics, Inc. (Nasdaq: OMGA) ("Omega"), today announced that it has received clearance of its Investigational New Drug (IND)...

United Kingdom Jason Braco Kevin Murphy Mahesh Karande Omega Epigenomic Lifesci Communications

Source: prnewswire.com